×
KRT fell from Wednesday's close of $32.29 to $30.57 by late morning Thursday, a -5.33% decline that occurred during the regular session after a marginally higher premarket quote. No verified news or fundamental catalyst found for Thursday's slide; roughly $0.47 of it — about -1.5% — reflects the $0.47 quarterly dividend going ex-dividend today, with the remainder consistent with a broad packaging-sector pullback and residual selling after the Nov. 5 third-quarter miss.
Synergy execution is the core earnings driver. Amcor is roughly 10% ahead of its first-year plan after the Berry Global combination, having captured about $285 million of synergies in fiscal 2026 toward a $650 million three-year target through fiscal 2028. Portfolio reshaping is accelerating. Management is divesting about $2.5 billion of non-core assets, including the North American beverage business, to sharpen focus on six higher-growth, higher-margin categories.
The central $49 stock price target is the arithmetic mean of eight verified, current analyst price targets, which range from roughly $44 to $56. Amcor plc (AMCR) last traded near $43.70, meaning the stock would need to rise about 12% to reach the $49 target.
Amcor plc (AMCR) trades near $43.70, down roughly 2.3% over the last 30 days, as a post-earnings pullback gave back an October rally. The pullback followed Amcor's November 4 report for the September 2026 quarter, when it lowered its six-month transition-period adjusted EPS outlook to $1.70–$1.80 from $1.80–$1.90.
Karat Packaging shares fell roughly 34.7% over the last 30 days, from a close of about $53.60 in mid-October to near $35.01, driven by a disappointing third-quarter earnings report. The company missed Wall Street's revenue and earnings expectations, with adjusted EPS of $0.24 falling well short of the roughly $0.46 consensus estimate.
IP delivered a margin inflection in its latest quarter, beating earnings estimates, while SW missed estimates and lowered its full-year outlook. Tickeron AI Verdict: IP — its improving earnings momentum and cleaner near-term catalysts give it the edge over SW .
The $5.50 target is not a published analyst consensus; it reflects publicly discussed market commentary (a Hold rating with a $5.50 price target noted by market data providers) alongside a major technical milestone — the stock's 52-week high of roughly $5.60. YHGJ has essentially no credible, current analyst price-target coverage; the handful of aggregated figures are thin, contradictory, or appear to reflect data errors, so no reliable arithmetic mean of analyst targets exists.
Biotech value-unlocking is the central theme. A proposed reverse merger involving the Impact BioMedical business is the most significant near-term catalyst that could alter how investors value the company's asset base. Cost discipline is improving the foundation. Total costs and expenses declined 43% in 2025, a structural change that could support operating leverage as revenue rebuilds.
The $1.00 central target is a fallback figure drawn from public valuation discussion, not an analyst consensus, because DSS has too few current, credible analyst price targets to form a meaningful average. The latest verified close is about $0.48 , so reaching $1.00 would require a gain of roughly 109% — a very large move by any standard.
DSS, Inc. shares fell roughly 22.5% over the trailing 30 days, as an early-September retail-driven surge continued to unwind. The decline extends a longer slide, with the stock down roughly 44% year to date and trading near the lower end of its 52-week range of $0.36 to $1.86.
DSS fell -4.08% during regular trading on Monday, easing from a previous close of $0.49 to $0.47. No verified news or fundamental catalyst found. The decline is likely ordinary volatility for this thinly traded micro-cap, consistent with its habit of large daily swings — equal or larger moves occurred on 13 of the prior 60 sessions.
The $0.70 target discussed here is not an analyst consensus. It is a technical objective drawn from public market commentary — specifically a move back to the stock's 200-day moving average, near $0.69. Only a single analyst price target is currently visible — roughly $3.00 — and it implies more than 500% upside, so it is too thin and too extreme to treat as a meaningful average analyst price target.
Reynolds Consumer Products (REYN) is a defensive consumer staples maker known for brands such as Reynolds Wrap and Hefty, while SoFi Technologies (SOFI) is a high-growth digital banking and financial-services platform. Relative performance has diverged sharply: SOFI has posted a strong multi-month rally, whereas REYN has lagged the broader market amid softer volumes and margin pressure.
Karat Packaging (KRT) plunged to $34.39 from a $51.44 prior close, a -33.15% drop, during regular market hours. The selloff followed Q3 results: adjusted EPS of $0.24 missed the ~$0.46 consensus and revenue of $134.7M missed ~$140.3M, with Q4 guidance also below estimates as freight, resin and shipping costs squeezed margins.
Karat Packaging reported third-quarter 2026 net sales of $134.7 million, up roughly 8% from $124.5 million a year earlier but below management's internal expectations. Net income attributable to Karat fell to $4.4 million, or $0.22 per diluted share, down from $7.3 million, or $0.36 per share, in the prior-year quarter as margins compressed.
Reynolds Consumer Products reported third-quarter 2026 net revenues of $944 million , up from $931 million a year earlier and above the roughly $939 million consensus estimate. Adjusted earnings per share (EPS) came in at $0.39 , edging past the consensus of about $0.38 but down from $0.42 in the prior-year quarter.
Amcor reported first-quarter fiscal 2027 adjusted earnings per share (EPS) of $0.95, slightly below the consensus estimate of roughly $0.98. Revenue reached $6.13 billion, up 6.6% year over year, topping analyst forecasts by approximately $230 million.
Graphic Packaging reported third quarter 2026 net sales of $2,192 million, roughly flat year over year but ahead of analyst consensus estimates of approximately $2.15 billion. Net income fell sharply to $22 million, or $0.07 per diluted share, from $142 million, or $0.48 per share, in the prior-year quarter.
Greif reported fiscal fourth-quarter 2026 net sales of $1.14 billion, topping the consensus estimate of roughly $1.09 billion. GAAP (Generally Accepted Accounting Principles) Class A earnings per share (EPS) came in at a loss of $0.11, weighed down by impairment charges tied to the Sweetwater paperboard mill closure and an unusually high effective tax rate.
Ball reported comparable diluted earnings per share (EPS) of $1.10 , up 6.8% year over year and above analyst consensus estimates. Net sales climbed 23.9% to $4.19 billion , beating expectations on stronger volumes and higher aluminum prices.